Merté H J, Heilmann K, Hollwich I
Klin Monbl Augenheilkd. 1977 Mar;170(3):473-9.
In the scope of a clinical-experimental study on 12 patients with chronic open-angle glaucoma we proved that a reduction in the individual doses of Acetazolamide (Diamox) brought no reduction in the effect on raised intraocular pressure when the frequency of application was the same. Daily doses of 3 X 125 mg were compared with those of 3-250 mg and 2 X 500 mg (Retardform). A additional trial on 6 patients with a daily dose of 3 X 62.5 mg also showed an obvious effect. The possibilities of long term treatment with acetazolamide are discussed.
在一项针对12例慢性开角型青光眼患者的临床实验研究范围内,我们证明,当用药频率相同时,减少乙酰唑胺(醋氮酰胺)的个体剂量并不会降低其对眼压升高的疗效。将每日3×125毫克的剂量与3×250毫克和2×500毫克(缓释剂型)的剂量进行了比较。另外一项针对6例患者、每日剂量为3×62.5毫克的试验也显示出明显疗效。文中还讨论了乙酰唑胺长期治疗的可能性。